Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer

Clinical trial NCT04443062 · COMPLETED

Trial details

NCT number: NCT04443062
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2020-07-20
Primary completion: 2025-04-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.